Clinical Research Directory
Browse clinical research sites, groups, and studies.
Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.
Sponsor: Abraham Hulst, MD, PhD
Summary
A multicentre, matched-pair, cluster randomised controlled superiority trial to investigate the effect of a proactive basal bolus insulin regimen compared to the reactive sliding scale insulin regimen, targeting a glucose level of 3.9-10.0 mmol/L, to reduce the number of surgical site infections within the first 30 days postoperatively in adult patients with diabetes mellitus type 2.
Official title: Postoperative Glucose Control with a Basal Bolus Versus Sliding Scale Insulin Regimen and Its Effect on the Incidence of Surgical Site Infections in People with Type 2 Diabetes Mellitus.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1008
Start Date
2025-01-03
Completion Date
2027-09
Last Updated
2025-01-30
Healthy Volunteers
No
Interventions
Basal bolus insulin regimen
Combination of long-acting and short-acting insulin in a proactive schedule for achieving better blood glucose values postoperatively
Locations (1)
Amsterdam UMC
Amsterdam, Netherlands